Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

August 01, 1988; Volume 246,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adler, M W

    1. You have access
      Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;
  2. Adrien, J

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  3. Akera, T

    1. You have access
      Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;
  4. Alberts, A W

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;
  5. Amoroso, S

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  6. Annunziato, L

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  7. Antolick, L

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  8. Asano, M

    1. You have access
      Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;
  9. Asano, T

    1. You have access
      Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;

B

  1. Baker, F E

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  2. Barnett, A

    1. You have access
      Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  3. Batt, A M

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  4. Batzri, S

    1. You have access
      Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;
  5. Beach, J E

    1. You have access
      Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;
  6. Berlin, J R

    1. You have access
      Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;
  7. Bigelow, G E

    1. You have access
      Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;
  8. Bixler, G B

    1. You have access
      WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;
  9. Bolger, M B

    1. You have access
      Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;
  10. Bose, R

    1. You have access
      Relaxant effect of amiloride on canine tracheal smooth muscle.
      I K Krampetz and R Bose
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 641-648;
  11. Bowker, P

    1. You have access
      Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;
  12. Brase, D A

    1. You have access
      Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;
  13. Brinton, R E

    1. You have access
      Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;
  14. Brion, N

    1. You have access
      Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  15. Brown, A D

    1. You have access
      Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  16. Brown, J C

    1. You have access
      Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;
  17. Brugada, O

    1. You have access
      Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;
  18. Buckley, J P

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  19. Bugelski, P J

    1. You have access
      Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  20. Bugianesi, R L

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

C

  1. Cameron, A M

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  2. Canzoniero, L M

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  3. Carbon, C

    1. You have access
      Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  4. Carlson, K

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  5. Caudle, R M

    1. You have access
      Influence of dynorphin (1-13) on spinal reflexes in the rat.
      R M Caudle and L Isaac
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 508-513;
  6. Chabala, J C

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;
  7. Chan, W Y

    1. You have access
      Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
      W Y Chan and V J Hruby
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 597-602;
    2. You have access
      Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats.
      W Y Chan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 603-609;
  8. Chelly, J E

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  9. Chen, Y F

    1. You have access
      Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;
  10. Chiang, P K

    1. You have access
      Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;
  11. Chiu, P J

    1. You have access
      Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  12. Christensen, S

    1. You have access
      Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;
  13. Clarke, P B

    1. You have access
      Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;
  14. Coffin, V L

    1. You have access
      Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
      R D Spealman and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 610-618;
  15. Coirini, H

    1. You have access
      Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

D

  1. Daniel, E E

    1. You have access
      Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;
  2. Danilo, P

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  3. DeLander, G E

    1. You have access
      Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
      G E DeLander and J J Wahl
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 565-570;
  4. Delatour, P

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  5. Dewey, W L

    1. You have access
      Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;
  6. Di Renzo, G F

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  7. Doursout, M F

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  8. Dubocovich, M L

    1. You have access
      Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices.
      J T Eells and M L Dubocovich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 514-521;

E

  1. Eaker, E Y

    1. You have access
      WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;
  2. Eells, J T

    1. You have access
      Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices.
      J T Eells and M L Dubocovich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 514-521;
  3. Eison, A S

    1. You have access
      Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;
  4. el-Fakahany, E E

    1. You have access
      Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  5. el Din, M M

    1. You have access
      Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
      M M el Din and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 479-484;
  6. Epstein, M

    1. You have access
      Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;

F

  1. Fattaccini, C M

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  2. Fein, H G

    1. You have access
      Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;
  3. Fibiger, H C

    1. You have access
      Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;
  4. Forster, M

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  5. Fu, D S

    1. You have access
      Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;

G

  1. Gaffney, T E

    1. You have access
      C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;
  2. Gallissot, M C

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  3. Gee, K W

    1. You have access
      Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;
  4. Geller, E B

    1. You have access
      Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;
  5. Gerhart, C

    1. You have access
      Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  6. Gerthoffer, W T

    1. You have access
      Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;
  7. Gianutsos, G

    1. You have access
      Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;
  8. Gozlan, H

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  9. Granata, A R

    1. You have access
      C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;
  10. Granett, J R

    1. You have access
      Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  11. Gray, J A

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  12. Gruenke, L D

    1. You have access
      Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;
  13. Gunnell, M

    1. You have access
      Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
  14. Gwirtz, P A

    1. You have access
      Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;

H

  1. Hadjiconstantinou, M

    1. You have access
      Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;
  2. Hagane, K

    1. You have access
      Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;
  3. Haim, K

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  4. Hamon, M

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  5. Harmon, J W

    1. You have access
      Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;
  6. Hartley, C J

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  7. Hayashi, K

    1. You have access
      Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;
  8. Herman, A G

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;
  9. Holgate, S T

    1. You have access
      Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;
  10. Holohan, P D

    1. You have access
      Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;
  11. Hoyt, D G

    1. You have access
      Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
      D G Hoyt and J S Lazo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 765-771;
  12. Hruby, V J

    1. You have access
      Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
      W Y Chan and V J Hruby
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 597-602;
  13. Hwang, S B

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

I

  1. Inoue, S

    1. You have access
      Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;
  2. Isaac, L

    1. You have access
      Influence of dynorphin (1-13) on spinal reflexes in the rat.
      R M Caudle and L Isaac
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 508-513;
  3. Ishida, Y

    1. You have access
      Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;

J

  1. Jakubovic, A

    1. You have access
      Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;
  2. Jin, H K

    1. You have access
      Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;
  3. Joly, V

    1. You have access
      Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  4. Jones, C E

    1. You have access
      Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;

K

  1. Kaparos, G

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
  2. Kavlock, R J

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  3. Khoyi, M A

    1. You have access
      Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;
  4. Kobayashi, M

    1. You have access
      Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;
  5. Konopka, K

    1. You have access
      Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;
  6. Koop, D R

    1. You have access
      Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;
  7. Kopia, G A

    1. You have access
      Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;
  8. Krampetz, I K

    1. You have access
      Relaxant effect of amiloride on canine tracheal smooth muscle.
      I K Krampetz and R Bose
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 641-648;
  9. Kwok, Y N

    1. You have access
      Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;

L

  1. Lam, M H

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;
  2. Lattin, D L

    1. You have access
      Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
  3. Lau, C

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  4. Lazo, J S

    1. You have access
      Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
      D G Hoyt and J S Lazo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 765-771;
  5. Leccese, A P

    1. You have access
      Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  6. Liebson, I A

    1. You have access
      Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;
  7. Loutzenhiser, R

    1. You have access
      Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;
  8. Lux, F

    1. You have access
      Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;

M

  1. Mahy, N

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  2. Malfatto, G

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  3. Malik, K U

    1. You have access
      Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
      M M el Din and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 479-484;
  4. Manning, D

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  5. Männistö, P T

    1. You have access
      Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;
  6. Marquis, K L

    1. You have access
      Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  7. Martin, P

    1. You have access
      Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;
  8. Masson, C

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  9. Masuzawa, K

    1. You have access
      Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;
  10. Mathias, J R

    1. You have access
      WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;
  11. Matsuda, T

    1. You have access
      Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;
  12. Matsumoto, M

    1. You have access
      Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  13. Mattia, A

    1. You have access
      Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  14. Maurano, F

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
  15. McEwen, B S

    1. You have access
      Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;
  16. McIntosh, C H

    1. You have access
      Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;
  17. Mehta, A K

    1. You have access
      Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels.
      A K Mehta and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 558-564;
  18. Minematsu, R

    1. You have access
      Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  19. Miyake, K

    1. You have access
      Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  20. Montastruc, J L

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;
  21. Moreton, J E

    1. You have access
      Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;
  22. Moroi-Fetters, S E

    1. You have access
      Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;
  23. Mothe, O

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  24. Muller, M J

    1. You have access
      Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;
  25. Murphey, K A

    1. You have access
      Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;

N

  1. Nagahama, S

    1. You have access
      Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;
  2. Nakahata, N

    1. You have access
      Bradykinin-induced contraction is inhibited by tiaramide, an anti-inflammatory drug, with an inhibition of increase in intracellular free calcium.
      N Nakahata and H Nakanishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 635-640;
  3. Nakanishi, H

    1. You have access
      Bradykinin-induced contraction is inhibited by tiaramide, an anti-inflammatory drug, with an inhibition of increase in intracellular free calcium.
      N Nakahata and H Nakanishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 635-640;
  4. Neff, N H

    1. You have access
      Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;
  5. Nishikibe, M

    1. You have access
      Effect of the calcium entry blocker NB-818 on cerebral blood flow after unilateral carotid occlusion in the Mongolian gerbil.
      M Nishikibe
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 719-725;

O

  1. Ohizumi, Y

    1. You have access
      Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;
  2. Ohlstein, E H

    1. You have access
      Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;
  3. Okunishi, H

    1. You have access
      Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;
  4. Orband-Miller, L

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  5. Owens, S M

    1. You have access
      Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;

P

  1. Pangon, B

    1. You have access
      Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  2. Paul, R

    1. You have access
      Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;
  3. Petersen, J S

    1. You have access
      Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;
  4. Phillips, G D

    1. You have access
      Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;
  5. Polk, M

    1. You have access
      Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
  6. Ponpipom, M M

    1. You have access
      Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;
  7. Preston, K L

    1. You have access
      Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;
  8. Privitera, P J

    1. You have access
      C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;
  9. Prost, J F

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

Q

  1. Queen, K L

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

R

  1. Rafferty, P

    1. You have access
      Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;
  2. Rauhala, P

    1. You have access
      Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;
  3. Regal, J F

    1. You have access
      Role of arachidonate metabolites in C5a-induced bronchoconstriction.
      J F Regal
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 542-547;
  4. Reis, D J

    1. You have access
      C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;
  5. Reisine, T

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  6. Rich, N M

    1. You have access
      Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;
  7. Ripich, G

    1. You have access
      Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;
  8. Robinson, C

    1. You have access
      Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;
  9. Rochat, C

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;
  10. Rosen, M R

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  11. Ross, C R

    1. You have access
      Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;
  12. Ruffolo, R R

    1. You have access
      Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;

S

  1. Sato, H

    1. You have access
      Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;
  2. Shalmi, M

    1. You have access
      Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;
  3. Shebuski, R J

    1. You have access
      Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  4. Shoji, N

    1. You have access
      Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;
  5. Siegel, M

    1. You have access
      Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;
  6. Siest, G

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  7. Slotkin, T A

    1. You have access
      Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;
  8. Smallridge, R C

    1. You have access
      Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;
  9. Smith, J M

    1. You have access
      Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  10. Sodowick, B

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  11. Sokol, P P

    1. You have access
      Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;
  12. Souhaili-El Amri, H

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  13. Spealman, R D

    1. You have access
      Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
      R D Spealman and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 610-618;
  14. Stitzer, M L

    1. You have access
      Cigarette brand-switching: effects on smoke exposure and smoking behavior.
      J P Zacny and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 619-627;
  15. Storer, B L

    1. You have access
      Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;
  16. Strader, J R

    1. You have access
      Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;
  17. Sy, H

    1. You have access
      Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;
  18. Szilagyi, J

    1. You have access
      Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

T

  1. Taglialatela, M

    1. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. You have access
      Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;
  2. Takeo, S

    1. You have access
      Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  3. Tanonaka, K

    1. You have access
      Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;
  4. Thermos, K

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;
  5. Thomas, J R

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;
  6. Ticku, M K

    1. You have access
      Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels.
      A K Mehta and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 558-564;
  7. Tiseo, P J

    1. You have access
      Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;
  8. Toda, N

    1. You have access
      Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;
  9. Totis, M

    1. You have access
      Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;
  10. Tuominen, R K

    1. You have access
      Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;

U

  1. Underwood, M D

    1. You have access
      C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

V

  1. Vallois, J M

    1. You have access
      Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;
  2. Verbeuren, T J

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

W

  1. Wahl, J J

    1. You have access
      Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
      G E DeLander and J J Wahl
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 565-570;
  2. Waskell, L A

    1. You have access
      Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;
  3. Welch, S P

    1. You have access
      Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;
  4. Wilkerson, R D

    1. You have access
      Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomic and central nervous systems.
      R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 466-471;
  5. Woolkalis, M

    1. You have access
      Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

Y

  1. Yocca, F D

    1. You have access
      Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;

Z

  1. Zacny, J P

    1. You have access
      Cigarette brand-switching: effects on smoke exposure and smoking behavior.
      J P Zacny and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 619-627;
  2. Zaza, A

    1. You have access
      Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;
  3. Zonnekeyn, L L

    1. You have access
      The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;
  4. Zorbas, M

    1. You have access
      Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 246, Issue 2
1 Aug 1988
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics